This paper provides a comprehensive, evidence-based framework for dietitians counseling patients who are using GLP-1 receptor agonists, such as Ozempic and Wegovy, for weight management. These medications are rapidly gaining popularity for their effectiveness in supporting weight loss; however, they come with unique nutritional considerations that require tailored guidance. This review outlines key aspects of GLP-1 mechanisms of action, emphasizing how these medications alter digestive processes, specifically impacting the absorption and metabolism of essential macronutrients, including proteins and dietary fibers. The paper also highlights hydration needs to support optimal health and weight loss outcomes in patients on GLP-1 therapies. Additionally, the paper presents surface-level recommendations for adjusting energy intake. Recognizing that micronutrient intake may be insufficient in some cases, the paper also explores specific supplements that can synergistically support the recommended dietary adjustments. These evidence-based guidelines are intended to serve as a reliable resource for dietitians, providing tools for them to deliver individualized nutrition care that maximizes the efficacy and safety of GLP-1-based weight loss interventions.
| Date of Award | Nov 27 2024 |
|---|
| Original language | English |
|---|
| Supervisor | Peterson (Supervisor) |
|---|